Virtual Heart Care

Background: Medicare’s Hospital Readmissions Reduction Program has focused on reducing the readmission rate in patients admitted for heart failure exacerbations.

Significant differences in the clinical presentation and outcomes of cardiovascular diseases in men and woman have been described in the

Background: Cardiovascular registries are built through expert abstraction of summary clinical information often represented as binary flags used to define

Introduction: Real-world 12-month outcomes of sacubitril/valsartan (sac/val) vs. ACEi or ARB use among patients with HFrEF (EF < 40%) through

Introduction: Stroke systems of care (SSOC) laws have been adopted across the US as early as 2002 to improve access

Abstract: SGLT2i have recently demonstrated efficacy in reducing acute CHF exacerbations, hospitalizations, and major adverse cardiac outcomes. Their efficacy in

Background: Racial and ethnic healthcare disparities contribute to significant morbidity, mortality, and healthcare costs in cardiovascular disease. As one of

Abstract: Coronary Artery Calcium (CAC) measurement and its usefulness to stratify patients by CAD risk remains an area of controversy.

Background: Different arrhythmias have been reported in patients with COVID-19 due to the complication of the disease, and medications used

Background: Cancer-specific adverse events are not well defined despite chronic kidney disease (CKD) being associated with high mortality rates in